LEVODOPA/CARBIDOPA GENERIS

Medicinal product

(Invented) name

LEVODOPA/CARBIDOPA GENERIS

Active substance (s)

Levodopa/Karbidopa

Strength

250 mg/25 mg

Pharmaceutical form

tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N04BA02, Levodopa and decarboxylase inhibitor

Marketing authorisation holder

UAB Niromed, Lietuva

Date of authorisation

2026-10-02

Date of renewal

Documents

3635_3636_Levodopa Carbidopa Generis_PZ_2026-10-02.docx

3635_3636_Levodopa Carbidopa Generis_PIL_2026-10-02.docx

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

Procedure number

Marketing authorisation procedure

Lygiagretus importas

Qualitative and quantitative composition

Tabletėje yra	1 vnt.
Levodopa	250 mg
Karbidopa	25 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
122539	108649	1108649	lizdinė plokštelė	N20		Receptinis	LT/L/26/3636/001	Netiekiama	-	-	No	-	-
122540	108650	1108650	lizdinė plokštelė	N60		Receptinis	LT/L/26/3636/002	Netiekiama	-	-	No	-	-	Download

Stadijos

Data	Stadija
2026-10-02	Registruotas